Skip to main content

GE Healthcare s Capto Q and Applied Biosystems Human Genome Survey Microarray V2.0


The Capto Q chromatography medium for protein purification was launched this week by GE Healthcare. The medium is “ideal” for use in capture and intermediate purification of high-expression, high-volume feeds, the company said in a statement. The medium features a “highly” rigid matrix for “wider” working range of flow velocities, bed heights, and sample viscosities, in addition to “high” flow velocities to “increase” volume throughput and “reduce” process time, the company added.

Applied Biosystems released the new Human Genome Survey Microarray V2.0 this week, the company said in a statement. Intended for use with the ABI Expression Array system, the new Survey Microarray contains 2,180 additional annotated genes, bringing the total number of annotated genes to 29,098, the company claimed.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.